Response to Plasmapheresis Measured by Angiogenic Factors in a Woman with Antiphospholipid Syndrome in Pregnancy

Table 1

Gestational age (weeks)	Plasmapheresis	Endoglin	sflt-1	plgf	Ratio
18 + 5	Before	22,57	4755	35,15	135,02
	After	13,09	6772	41,19	164,34
	Following day	17,73	7512	50,46	135,25
19 + 5	Before	21,33	5714	30,35	188,27
	After	11,46	12264	55,31	322,21
	Following day	14,62	6109	38,87	160,29
20 + 5	Before	16,88	5983	36,47	164,05
	After	9,45	14801	85,94	174,21
	Following day	11,38	3989	26,35	153,55
22 + 5	Before	16,92	9325	51,57	180,82
	After	10,78	16850	146,9	115,36
	Following day	10,89	7241	29,4	249,54
24 + 5	Before	18,81	10304	36,87	279,46
	After	11,12	18040	149,7	121,73
	Following day	14,05	8563	42,54	203,01
26 + 5	Before	31,38	16600	52,87	313,97
	After	18,27	48045	171,9	280,29
	Following day	23,81	11209	40	265,57
27 + 5	Before	48,15	24618	55,62	442,61
	After	21,18	>85000	181,3	468,25
	Following day	33,28	12988	48,96	270,52
14.12.2013	Caesarean section due to placental abruption
16.12.2013	2 days postpartum	10,15	1190	16,76	71
23.12.2013	One week postpartum	4,65	188	18,57	10,12